Literature DB >> 15618170

Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells.

Klaus Panthel1, Katrin M Meinel, Victòria E Sevil Domènech, Heike Retzbach, Emeka I Igwe, Wolf-Dietrich Hardt, Holger Rüssmann.   

Abstract

Salmonella enterica serovar Typhimurium employs two different type III secretion systems (TTSS) encoded within Salmonella pathogenicity islands 1 and 2 (SPI1 and SPI2) for targeting of effector proteins into the cytosol of eukaryotic cells during different stages of the infection cycle. The SPI1 TTSS translocates virulence factors across the plasma membrane when the bacterium initially contacts the host cell. In contrast, the SPI2 TTSS functions to translocate proteins across the membrane of the Salmonella-containing vacuole and promotes intracellular survival and replication. The aim of the present study was to directly compare the potentials of SPI1 and SPI2 type III effector proteins to act as carrier molecules for a heterologous antigen. The p60 protein of Listeria monocytogenes was used as a model antigen to construct chimeric SopE2 (SPI1), SifA (SPI2), and SspH2 (SPI2) proteins. SPI1- and SPI2-dependent up- and down-regulation of hybrid gene expression led to sequential translocation of p60 fusion proteins into the cytosol of Salmonella-infected macrophages. Mice orally immunized with recombinant Salmonella strains expressing these hybrid proteins revealed comparable numbers of p60-specific CD8 T cells. However, only overexpression of translocated SspH2/p60 from a medium-copy-number vector induced simultaneous antigen-specific CD4 and CD8 T-cell responses, suggesting that SspH2 is an attractive carrier molecule for foreign-protein delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618170      PMCID: PMC538990          DOI: 10.1128/IAI.73.1.334-341.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Strategies for immunotherapy of cancer.

Authors:  C J Melief; R E Toes; J P Medema; S H van der Burg; F Ossendorp; R Offringa
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell.

Authors:  S Stender; A Friebel; S Linder; M Rohde; S Mirold; W D Hardt
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

3.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.

Authors:  N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

4.  Identification of SopE2, a Salmonella secreted protein which is highly homologous to SopE and involved in bacterial invasion of epithelial cells.

Authors:  C S Bakshi; V P Singh; M W Wood; P W Jones; T S Wallis; E E Galyov
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

5.  Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua.

Authors:  G Geginat; T Nichterlein; M Kretschmar; S Schenk; H Hof; M Lalic-Mülthaler; W Goebel; A Bubert
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

6.  Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems.

Authors:  E A Miao; C A Scherer; R M Tsolis; R A Kingsley; L G Adams; A J Bäumler; S I Miller
Journal:  Mol Microbiol       Date:  1999-11       Impact factor: 3.501

Review 7.  Salmonella pathogenicity island 2.

Authors:  M Hensel
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

8.  Salmonella maintains the integrity of its intracellular vacuole through the action of SifA.

Authors:  C R Beuzón; S Méresse; K E Unsworth; J Ruíz-Albert; S Garvis; S R Waterman; T A Ryder; E Boucrot; D W Holden
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

9.  Early programming of T cell populations responding to bacterial infection.

Authors:  R Mercado; S Vijh; S E Allen; K Kerksiek; I M Pilip; E G Pamer
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

10.  A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes.

Authors:  G Geginat; S Schenk; M Skoberne; W Goebel; H Hof
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

View more
  11 in total

1.  Optimization of a type III secretion system-based Pseudomonas aeruginosa live vector for antigen delivery.

Authors:  Olivier Epaulard; Madiha Derouazi; Carole Margerit; Raphaël Marlu; Didier Filopon; Benoît Polack; Bertrand Toussaint
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

2.  Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens.

Authors:  Wael Abdel Halim Hegazy; Xin Xu; Leonid Metelitsa; Michael Hensel
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

Review 3.  Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Authors:  James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Cell Biol       Date:  2009-05-05       Impact factor: 5.126

4.  Improved expression systems for regulated expression in Salmonella infecting eukaryotic cells.

Authors:  Carlos Medina; Eva María Camacho; Amando Flores; Beatriz Mesa-Pereira; Eduardo Santero
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

5.  Recombinant Salmonella expressing SspH2-EscI fusion protein limits its colonization in mice.

Authors:  Maozhi Hu; Weixin Zhao; Wei Gao; Wenhua Li; Chuang Meng; Qiuxiang Yan; Yuyang Wang; Xiaohui Zhou; Shizhong Geng; Zhiming Pan; Guiyou Cui; Xinan Jiao
Journal:  BMC Immunol       Date:  2017-05-03       Impact factor: 3.615

Review 6.  Intracellular delivery of biologic therapeutics by bacterial secretion systems.

Authors:  Barnabas James Walker; Guy-Bart V Stan; Karen Marie Polizzi
Journal:  Expert Rev Mol Med       Date:  2017-04-06       Impact factor: 5.600

7.  Immunization with recombinant Salmonella expressing SspH2-EscI protects mice against wild type Salmonella infection.

Authors:  Maozhi Hu; Weixin Zhao; Hongying Li; Jie Gu; Qiuxiang Yan; Xiaohui Zhou; Zhiming Pan; Guiyou Cui; Xinan Jiao
Journal:  BMC Vet Res       Date:  2018-03-09       Impact factor: 2.741

Review 8.  Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy.

Authors:  Ze Mi; Zhi-Chao Feng; Cheng Li; Xiao Yang; Meng-Tian Ma; Peng-Fei Rong
Journal:  J Cancer       Date:  2019-08-20       Impact factor: 4.207

9.  Identification of salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar typhimurium: implications for rational vaccine design.

Authors:  Rita Figueira; Kathryn G Watson; David W Holden; Sophie Helaine
Journal:  mBio       Date:  2013-04-16       Impact factor: 7.867

10.  Immunity to intracellular Salmonella depends on surface-associated antigens.

Authors:  Somedutta Barat; Yvonne Willer; Konstantin Rizos; Beatrice Claudi; Alain Mazé; Anne K Schemmer; Dennis Kirchhoff; Alexander Schmidt; Neil Burton; Dirk Bumann
Journal:  PLoS Pathog       Date:  2012-10-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.